In addition to the known effects of GLP1R on blood sugar regulation and stimulation of the hypothalamus to regulate appetite, studies have shown that GLP1R agonists have neuroprotective effects in different animal models of PD. This evidence concerns the gene GLP1R and Parkinson disease.